Efficacy and Safety of Bevacizumab Biosimilar FKB238 Versus Originator Bevacizumab: Results from AVANA, a Phase III Trial in Patients with Non-Squamous Non-Small-Cell Lung Cancer (non-sq-NSCLC).

paclitaxel - Generic mfg.

Equidacent (bevacizumab biosimilar) - Fujifilm Kyowa Kirin Biologics, AstraZeneca, Centus Biotherap

carboplatin - Generic mfg.

Avastin (bevacizumab) - Roche

http://www.ncbi.nlm.nih.gov/pubmed/34264503

Jul 16, 2021